Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
B-Raf/MEK/ERK pathway
.
Show all posts
Showing posts with label
B-Raf/MEK/ERK pathway
.
Show all posts
Monday, January 14, 2013
Melanomas that develop resistance to vemurafenib also become addicted to the drug
›
Vemurafenib ( marketed as Zelboraf ) is a B-Raf enzyme inhibitor developed by Plexxikon (now part of the Daiichi Sankyo group) and...
›
Home
View web version
